APT-3111

N/A

Report date: 2023/05/06 11:13:44

Base Information

Drug NameAPT-3111
Drug Alias NameCD59-ProdaptinAPT-2392
ClassificationBiologics
Mechanisms of ActionCD59 glycoprotein agonists
TargetsCD59 glycoprotein
Therapy Area/IndicationsHemoglobinuria, Paroxysmal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInflazyme Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHemoglobinuria, Paroxysmal

Other Information

ATC CodeN/A
Related LinksN/A